57 results about "Nerves pain" patented technology

An allergy skin test device is disclosed that causes less pain than commonly used devices that include multi-point sharp puncture heads. The allergy skin test device incorporates multiple dull pressure heads distributed amongst the sharp multi-point sharp puncture heads, each dull pressure head activating a neurological pain gate that reduces pain sensation typically caused by the neighboring multi-point head when it engages the skin.

The invention relates to a neuropathic pain therapeutic instrument, which belongs to the technical field of medical apparatuses. The neuropathic pain therapeutic instrument comprises a body. The upper side of the body is provided with a patient creeper, and the patient creeper is provided with a protection bedsheet. The protection bedsheet is provided with a patient pillow. The front side of the body is provided with a ventilating opening. The inner side of the ventilating opening is provided with a shutter blade rotating shaft fixing hole, where a shutter blade rotating shaft is disposed. The shutter blade rotating shaft is provided with a shutter blade. The left side of the ventilating opening is provided with a blade control wheel mounting groove. The blade control wheel mounting groove is provided with a blade control wheel. The left side of the body is provided with a power supply contactor mounting frame. The power supply contactor mounting frame is provided with a power supply contactor. The neuropathic pain therapeutic instrument is advantageous in that functions are complete and use is convenient; when neuropathic pain treatment is conducted on a patient, the instrument saves time and labor, and is scientific and convenient, safe and efficient, intelligent and accurate; work difficulty for medical staffs can be reduced.

The invention relates to a medicament for treating arthralgia and myalgia. The medicament is prepare from the components in parts by weight as follows: 1000 parts of nux vomica, 100 parts of radix clematidis, 100 parts of caulis sinomenii, 100 parts of garden balsam stem, 100 parts of lycopodium clavatum, 100 parts of berba aristolochiae mollissimae, 100 parts of monkshood, 100 parts of radix aconiti agrestis, 100 parts of the root of red-rooted salvia, 100 parts of angelica sinensis, 100 parts of rheum officinale, 100 parts of dragon's blood, 100 parts of semen momordicae, 100 parts of eucommia ulmoides, 100 parts of cinnamon, 100 parts of radix angelicae pubescentis, 100 parts of notopterygium root, 100 parts of asarum, 100 parts of radix achyranthis bidentatae, 100 parts of homalomena occulta, 100 parts of anisetree bark, 100 parts of radices sileris, 100 parts of caper, 100 parts of monkshood, 100 parts of ligusticum wallichii, 100 parts of Chinese polyphaga, 100 parts of scorpio, 100 parts of centipede, 100 parts of frankincense, 100 parts of myrrh, 100 parts of leech, 60 parts of camphor, 60 parts of borneol, 20 parts of musk and 300 parts of zaocys dhumnade. The medicament provided by the invention can be used for treating cervical spondylosis, brain swelling cervical pain, scapulohumeral periarthritis, scapula back pain, pelvospondylitis, thoracic vertebra pain, elbow joint pain, pain in waist and lower extremities, lumbar disc herniation, cervical and lumbar spinal stenosis, osteoproliferation, ischiadic nerve pain, knee-joint dropsy, synovitis, knee pain and rheumatic arthritis.

The electromagnetic stimulation device contains at least a positive electrode and at least a negative electrode. An insulating gap having width of a first distance is maintained between the positive and negative electrodes. The positive and negative electrodes are at least at a second distance away from a nerve to be stimulated. A preset voltage is applied to the positive and negative electrodes so that a low-power, low-temperature, high-frequency electromagnetic field covering and stimulating the nerve is produced between the positive and negative electrodes. By the stimulation of the low-power, low-temperature, high-frequency electromagnetic field, the nerve's threshold is increased, the nerve's transmission capability is reduced, and therefore the nerve pain is effectively eased.

The invention provides a gastrodine injection, which comprises the forms of gastrodine water for injection and metal chelating agent, the invention also discloses its preparation and use. Wherein the preparation comprises depositing gastrodine with water, cold storing, ultrafiltration technology processing, and sterilizing. The injection can be used for treating brain trauma, megrims, nerve pain, cephalodynia and neurasthenia.

The invention discloses an analgesic bone rheumatoid plaster. The analgesic bone rheumatoid plaster has the functions of relaxing tendons, activating blood circulation, removing blood stasis, dispelling pathogenic wind, dispelling cold, removing dampness, stimulating the menstrual flow, activating collaterals, invigorating bone, relieving pain, resolving hard mass, and the like. The indications comprise bumps, fall injuries, pain on wounds, intercostal neuralgia, lumbar sprain, chest pain, pain in neck, shoulder, waist and lower extremities, rheumatism, rheumatoid arthritis, bone hyperplasia, bone spur, gout, bone fractures, neuropathic pain, and the like, and the efficacy is remarkable. The analgesic bone rheumatoid plaster is characterized in that the plaster can be directly pasted without heating when in application, and the paste oil can not be flowed anywhere and only leave a light mark, thereby not affecting the sanitation and not generating a wound surface on the skin by long-term application.

A treatment is described for diseases with symptoms that can include fatigue, muscle aches and spasms, weakness, demylenation, and nerve pain. Diseases can include fibromyalgia, depression, and auto-immune and immuno-suppressive diseases, such as MS. The treatment comprises about 1-10 mg naltrexone, at least about 20 μg vitamin B12, at least about 5 mg vitamin B6, at least about 2 mg coenzyme Q, and preferably at least one ancillary medication selected from the group consisting of diazepam, cyclcobenzaprine, clonazepam, alprazolam, 9-tetrahydrocannibinol, fumarate, caffeine, and combinations thereof. The treatment can be administered orally, and can decrease mental and physical symptoms such as, for example, fatigue, gait problems, visual dysfunction, and pain while improving cognitive skills.

The present disclosure relates to methods for treating diseases or conditions with pulsed electromagnetic field therapy, where the disease or condition treated is one susceptible to modulation of gene expression by pulsed electromagnetic field therapy. The present disclosure generally relates to methods of modulating gene expression and biological regulatory pathways with pulsed electromagnetic field therapy for treating diseases or conditions associated with such gene expression or regulatory pathways that are susceptible to modulation by pulsed electromagnetic therapy, including diseases or conditions associated with inflammation, nerve pain and wound repair.

The invention discloses application of an aryl piperazine compound shown in a formula (I) in preparing medicines for treating acute pain, nerve pain and nociceptive pain of mammals including human beings. The medicines are particularly suitable for treating complex pain caused by various reasons.

The present disclosure relates to methods for treating diseases or conditions with pulsed electromagnetic field therapy, where the disease or condition treated is one susceptible to modulation of gene expression by pulsed electromagnetic field therapy. The present disclosure generally relates to methods of modulating gene expression and biological regulatory pathways with pulsed electromagnetic field therapy for treating diseases or conditions associated with such gene expression or regulatory pathways that are susceptible to modulation by pulsed electromagnetic therapy, including diseases or conditions associated with inflammation, nerve pain and wound repair.

The invention relates to a field of Chinese and Western medicine clinical dermatology. Specifically, the invention relates to a traditional Chinese medicine used for treating pains caused by nerve damages caused by varicella-zoster virus which invades the nerves. The invention aims at providing a formula of a traditional Chinese medicine used for treating nerve pain caused by varicella-zoster virus which invades the nerves. The provided traditional Chinese medicine is herpes pain-relieving powder. The herpes pain-relieving powder is characterized in that: the powder is prepared from 10g of giant typhonium tuber, 10g of scorpion, 10g of cassiabarktree twig, 15g of pangolin scales, 6g of dragon's blood, 10g of ligusticum, 15g of Mongolian milkvetch root, 10g of Szechwan lovage rhizome, 10g of salvia miltiorrhiza, 10g of nutgrass galingale rhizome, 6g of combined spicebush root, 10g of immature tangerine fruit, 10g of corydalis tuber, 10g of safflower, 10g of peach seed, 10g of white peony root, 10g of prepared rhizome of rehmannia, 15g of American ginseng, 10g of Szechwan chinaberry fruit, 6g of Chinese caterpillar fungus, and the like. The materials are physically dried by baking, and are grinded into powder with a specification of 120 meshes. For an adult, the medicine is taken after mixed with water; 20g is taken each day, twice a day, and 10g each time.

The invention relates to a rhodiola rosea extract, an extraction method thereof, application thereof to treatment / prevention of an eye disease and a product containing the extract. The extraction method comprises the following steps: (1) treating raw materials to obtain raw material powder; (2) extracting an expansion system to obtain a crude extract; (3) performing liquid-liquid extraction by using an inorganic solution and an organic solvent to obtain a refined extract; (4) performing column chromatography separation to obtain the rhodiola rosea extract. The extract has a good effect of treating / preventing eye diseases such as asthenopia, xerophthalmia and eye nerve pains and can be prepared into an eye pad form so that the extract is convenient to use, safe and nontoxic and has good application prospects and industrial potentiality in the clinic field.

The present invention is directed to the treatment of chronic pain that occurs in chronic disease such as chronic pancreatitis by the application, of the drug, resiniferatoxin, to a visceral organ, such as the stomach, which then reduces the pain present in a second visceral organ, such as the pancreas. The reduction of said pain associated with the chronic disease occurs through the drug-induced desensitization of primary pain-sensing neurons that are shared between the two visceral organs. Additionally, application of the drug resiniferatoxin into the first organ, reduces the inflammation that occurs in the second diseased organ. This modulation of shared nerve activity by application of resiniferatoxin, may also be directed to modulate the pain and inflammation in any two visceral organs that share a common spinal or vagal nerve. Finally, application of the drug resiniferatoxin to either the stomach or the jejunum may be used to treat disease and disorders that involve gastroparesis. The resiniferatoxin improves gastric emptying and reduces nausea, thus may be effective therapy for these conditions.

The electromagnetic stimulation device contains at least a positive electrode and at least a negative electrode. An insulating gap having width of a first distance is maintained between the positive and negative electrodes. The positive and negative electrodes are at least at a second distance away from a nerve to be stimulated. A preset voltage is applied to the positive and negative electrodes so that a low-power, low-temperature, high-frequency electromagnetic field covering and stimulating the nerve is produced between the positive and negative electrodes. By the stimulation of the low-power, low-temperature, high-frequency electromagnetic field, the nerve's threshold is increased, the nerve's transmission capability is reduced, and therefore the nerve pain is effectively eased.

The invention belongs to the skin care product category of skin cleaning and maintenance, and is characterized by using a water soluble compound containing boron, iodine, bromine, selenium, potassium, sodium, chloride, zinc and other elements to prepare powder, and using 1000 times of water to dissolve the powder into high quality mineral water and sea water for washing the face or taking a shower. The product is based on the analysis of components of domestic and foreign high-quality mineral water and sea water, and uses research results of dermatology and cosmetology to achieve the purpose "deriving from the nature but higher than the natural". People may not be restricted by time and place, and can enjoy achievements brought by scientific and technological progresses. The product can clear away dead skin and excess fat on skins, relax the muscles and stimulate the blood circulation, eliminate fatigue, strengthen brain and soothe the nerves, diminish inflammation and relieve itching, soften, tender and beauty the skins and the like, has certain effects on chronic dermatitis, arthritis, relieving muscle and nerve pains and the like. The product shows good effects by use of thousands of people. This product production has the advantages of low production cost and simple technology, and has the value of popularization.

The invention provides a biological pulsation near-infrared therapeutic apparatus which is used for quickly treating muscle pain, neuropathic pain, arthritis, rheumatoid diseases and inflammatory pain, and assisting treatment on various liver diseases. The apparatus provided by the invention has the advantages of remarkable treatment effect, less contraindication and low recurrence rate, can be used for achieving a developed medical equipment product, and can be widely applied to pain and rehabilitation therapy. Along with medical service improvement in China and coming of an aging population society, a more general requirement on pain treatment and liver disease treatment is generated, so the biological pulsation near-infrared therapeutic apparatus has the characteristics of industrial popularization and application prospect and remarkable social and economical benefits.

The invention discloses a nerve pain and cardiovascular and brain vessel disease treating drug, which is characterized by the following: adopting sleeper, amber and mint as raw material; treating insomnia, anxiety, mania and schizophrenosis; improving immune function; resisting aging.

The invention relates to a compound medicament which comprises gastrodine and ligustrazine by the weight ratio of (0.1-100) : 1, and can be used for the synergic increase blood flow of coronary artery and brain. The medicament can be used for the treatment of nervous prostration syndrome, brain trauma syndrome, megrims, nerve pain, cephalalgia, cerebral embolism, cerebral hemorrhage, coronary disease, angina pectoris and myocardial infarction.

The invention relates to application of ginkgolic acid in pain alleviation. The ginkgolic acid comprises ginkgo acid, ginkgol, ginkgo diphenol and the like, and can be obtained from an extract of leaves, fruits, testa, rhizomes and the like of ginkgo by a chemical separation method. The pain comprises nerve pain, bone pain, muscle pain, tendon ligament pain, cancer pain and the like. A medicament, a medical instrument, a cosmetic or a disinfectant containing the ginkgolic acid and having a purpose of alleviating pain contains 0.001 to 80 weight percent of ginkgolic acid and pharmaceutically common external preparation matrix or acceptable carrier; and the preparation is any one of pharmaceutical external formulations. Pharmacological experimental research shows that the ginkgolic acid has an obvious effect of improving pain threshold on pain response caused by physical, chemical and cancerous stimulus. Clinical trials show that the ginkgolic acid has a remarkable alleviating effect on various pains and is predominant in curative effect, the effective rate reaches over 95 percent, and the ginkgolic acid is safe in use and does not have side effect.

The invention relates to the technical field of medical treatment, and discloses a rehabilitation training device based on human habits in the neurology department. The rehabilitation training devicebased on human habits in the neurology department includes a glove, a rehabilitation exercise mechanism and a power source mechanism, wherein the glove is provided with exposed fingers, the interior of the glove is hollow, and the rehabilitation exercise mechanism is fixedly installed in the glove; and the power source mechanism is fixedly installed on one side of the rehabilitation exercise mechanism, and the power source mechanism is located outside the glove. Through arrangement of the glove, not only can hands of a user be protected through the protective function of the glove, but also heat can be accumulated in the hands of the user through the thermal insulation function of the glove, so that the excitability of pain-sensitive nerves is reduced, blood circulation is improved, inflammatory edema is reduced, the nerve pain which is caused during rehabilitation training of the user is reduced, and the effect of rehabilitation training is improved; and through arrangement of the rehabilitation exercise mechanism, heat is generated through friction which is caused by circular slide of a piston cylinder B, and then the heat is transmitted to the glove, so that the glove has a heating function.

The invention discloses a Bozhou moutan cortex traditional Chinese medicine preparation and a preparation method thereof. The traditional Chinese medicine preparation comprises a plurality of traditional Chinese medicine materials with the effects of clearing away heat and relieving exterior syndromes, diminishing inflammation and alleviating pain, takes Bozhou moutan cortex as a main component and also takes rhizoma coptidis, radix scutellariae, flos lonicerae, rhizoma cimicifugae and liquorice root, and the traditional Chinese medicine preparation is prepared by the steps of extraction of the Bozhou moutan cortex, extraction of other traditional Chinese medicine components, mixing of auxiliary materials, potting and sterilization. The effective ingredients in the Bozhou moutan cortex areextracted by special multi-stage distillation equipment, so that the content and purity of anti-inflammatory and analgesic ingredient paeonol are high, the traditional Chinese medicine preparation has significant effects on muscle pain, visceral pain, rheumatic pain and nerve pain through curative effect verification, clears away heat and alleviates pain, the effective rate reaches 83.3-90%, andthe traditional Chinese medicine preparation is suitable for industrial production.

Systems and methods of reducing pain after surgery in the thoracic or abdominal region and managing chronic nerve pain in the thoracic or abdominal region are provided. Such methods involve an electrode assembly that has a proximal portion and a distal portion with the distal portion including a plurality of electrodes. At least one electrode of the plurality of electrodes is placed over each of a plurality of intercostal nerve bundles in the patient's body. The proximal portion of the electrode assembly is connected to a pulse generator. An electromagnetic field is applied to the plurality of intercostal nerve bundles. The plurality of electrodes is removed from the patient's body after an intercostal nerve block sufficient to alleviate the patient's pain has been achieved.

Compositions comprising Cannabidiol in combination with non-steroidal anti-inflammatory drugs (NSAIDs) are provided for treating conditions such as sciatica and other nerve pain.

It is an object of the invention to isolate a transporter responsible for ATP transport and a gene encoding the transporter. It is another object of the invention to provide a method for the screening of a medicament for treating and / or regulating pain in central nerves, blood coagulation by platelet-derived ATP, or the like, the method employing such a transporter. According to the invention, a transporter responsible for ATP transport and a gene encoding the transporter were isolated. Furthermore, there is provided a method for the screening of a medicament for treating and / or regulating pain in central nerves, blood coagulation by platelet-derived ATP, or the like, the method employing such a transporter.

The present invention relates to a traditional Chinese medicine composition for treating cancer pain, and applications thereof, wherein the active components of the traditional Chinese medicine composition comprise, by weight, 2-15 parts of cyperus rotundus l, 2-15 parts of panax notoginseng, 2-15 parts of ligusticum chuanxiong hort, 2-15 parts of angelica sinensis, 1-5 parts of daemonorops draco bl, 30-45 parts of clove bud, 10-25 parts of tetradium ruticarpum, and 2-8 parts of catechu. According to the present invention, the traditional Chinese medicine composition has effects of spleen and stomach warming and nourishing, detoxifying, stasis removing, anticancer and pain stopping, can be used for treating patients with gastric precancerous lesion caused by intermingled deficiency and excess and intermingled cold and heat, can improve the symptoms (such as gastric distention, stomach pain and dyspeptic retention) of patients, can resist the tumor-induced nerve pain of nude mice bearing ASG gastric cancer transplanted tumors, and can provide significant analgesic effect for painful mice.

The invention relates to a traditional Chinese medicine preparation for treating muscle and nerve pain and cancer pain. The traditional Chinese medicine preparation is prepared from 30 to 50 parts ofpine needle, 60 to 150 parts of walnut green husk, 50 to 90 parts of phoenix tree leaves, 40 to 80 parts of achyranthes aspera, 20 to 40 parts of resin of sweetgum, 60 to 150 parts of herb of humulusscandens and 10 to 20 parts of armadillidium. The preparation form is a capsule, a granule, a tablet, a pill, oral liquid or an external use oiling agent.

Methods and compositions are provided for inhibiting or treating metastasis based on discoveries regarding Kif19 and Cep192. Methods and compositions are provided for enhancing wound healing, treating fibrosis, reducing scarring and treating nerve pain.

The invention provides a safranine salt bath agent, wherein the constituent percentage by weight of the composition are, purpureaholite 60-95, Chinese prickly ash powder 1-10, corn poppy powder 1-10, sea-buckthorn powder 1-10, egg membrane powder 1-10, tomato powder 1-10, the agent is prepared through mixing the raw materials. The bath agent can simulate the action of hot spring in treating knuckle ache, nerve pain, pollen irritability, rheumatism pain and beriberi.